Transpact Enterprises Ltd.

394.20 ▼0%

27 March 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.transpact.in
Market Cap 15.24 Cr.
Enterprise Value(EV) 15.27 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.70 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 58.10 Trailing Twelve Months Ending 2023-03
Book Value / Share 13.79 Trailing Twelve Months Ending 2023-03
Price to Book Value 28.58 Calculated using Price: 394.20
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.04 Cr. 386,730 Shares
FaceValue 10
About Transpact Enterprises Ltd.
Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Transpact Enterprises Ltd. Delivery

Delivered Qty
Traded Qty

Transpact Enterprises Ltd. Performance

1 Day
1 Week
-4.99%
1 Month
-4.99%
3 Month
+10.58%
6 Month
+97.20%
1 Year
+314.95%
2 Year
+165.81%
5 Year
10 Year

Transpact Enterprises Ltd. Fundamental Ratios

7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -27.59 -77.28 -804.02 -97.83 -7.53 -31.12 -11.64
Return on Capital Employed (%) -19.45 -27.62 -66.2 -53.57 -5.23 -21.88 -7.88
Return on Assets (%) -19.19 -25.93 -60.34 -47.48 -4.78 -17.8 -6.14

Transpact Enterprises Ltd. Balance Sheet

Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 0 1 1 1 1 0
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 0 0 0 1 0 0 0
Minority Int.
Equity & Liab. 0 0 1 1 1 1 1 1
Non Curr. Assets 0 0 0 1 1 1 1 0
Curr. Assets 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 1 1 1 1 1 1

Transpact Enterprises Ltd. Profit and Loss

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0
Interest
Depreciation 0 0 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0
Adjusted EPS -2 -3 -11 -11 -2 -6 -2

Transpact Enterprises Ltd. Cash Flow

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 -1 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 1 0 0 0
Net Change 0 0 0 -1 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0

Transpact Enterprises Ltd. Shareholding Pattern

9 Qtrs 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%) 2023-09 (%)
Promoter 45.89 45.89 45.89 45.89 45.89 45.89 45.89 32.63 0.13
Public 54.11 54.11 54.11 54.11 54.11 54.11 54.11 67.37 99.87
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Transpact Enterprises Ltd. Announcements

Sat, 23 Mar 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Additional Details required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13 2023 for Corporate Announcement regarding Resignation of Company Secretary
Wed, 20 Mar 2024
Shareholder Meeting - EGM On April 12 2024 (Friday)
Extraordinary General Meeting to be held on Friday April 12 2024 at 11.00 A.M. through Video Conference (VC)/ Other Audio- Visual Means (OAVM)
Fri, 15 Mar 2024
Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Amrita Gupta (ACS No. 44487) as the Company Secretary and Compliance officer of the Company

Transpact Enterprises Ltd. Technical Scans

Wed, 27 Mar 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Low Close Crossing Last Month Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Transpact Enterprises Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Transpact Enterprises Ltd. FAQ's

What is Transpact Enterprise share price?

Can I buy Transpact Enterprise shares now?

What is the Market Cap of Transpact Enterprise?

What are the key metrics to analyse Transpact Enterprise?

What is the 52 Week High and Low of Transpact Enterprise?